Skip to main content
Article
Mantle Cell Lymphoma International Prognostic Index but Not Pretransplantation Induction Regimen Predicts Survival for Patients With Mantle-Cell Lymphoma Receiving High-Dose Therapy and Autologous Stem-Cell Transplantation
Journal of Clinical Oncology (2011)
  • Lihua E. Budde, Fred Hutchinson Cancer Research Center
  • Katherine A. Guthrie, Fred Hutchinson Cancer Research Center
  • Brian G. Till, Fred Hutchinson Cancer Research Center
  • Oliver W. Press, Fred Hutchinson Cancer Research Center
  • Thomas R. Chauncey, Fred Hutchinson Cancer Research Center
  • John M. Pagel, Fred Hutchinson Cancer Research Center
  • Steven H. Petersdorf, Fred Hutchinson Cancer Research Center
  • William I. Bensinger, Fred Hutchinson Cancer Research Center
  • Leona A. Holmberg, Fred Hutchinson Cancer Research Center
  • Andrei R. Shustov, Fred Hutchinson Cancer Research Center
  • Damian J. Green, Fred Hutchinson Cancer Research Center
  • David G. Maloney, Fred Hutchinson Cancer Research Center
  • Ajay K. Gopal, Fred Hutchinson Cancer Research Center
Publication Date
January 8, 2011
DOI
10.1200/JCO.2010.33.7055
Citation Information
Lihua E. Budde, Katherine A. Guthrie, Brian G. Till, Oliver W. Press, et al.. "Mantle Cell Lymphoma International Prognostic Index but Not Pretransplantation Induction Regimen Predicts Survival for Patients With Mantle-Cell Lymphoma Receiving High-Dose Therapy and Autologous Stem-Cell Transplantation" Journal of Clinical Oncology Vol. 29 Iss. 22 (2011) p. 3023 - 3029
Available at: http://works.bepress.com/john-pagel/182/